Disclosures for "GAA-FGF14 Disease: Defining Its Frequency, Molecular Basis, and 4-aminopyridine Response in a Large Cohort of Patients with Downbeat Nystagmus"
-
Dr. Pellerin has nothing to disclose.
-
Mr. Heindl has nothing to disclose.
-
Dr. Wilke has nothing to disclose.
-
Matt Danzi has nothing to disclose.
-
-
Dr. Ashton has nothing to disclose.
-
-
Miss Cuillerier has nothing to disclose.
-
Dr. Del Gobbo has nothing to disclose.
-
The institution of Kym Boycott has received research support from Genome Canada. The institution of Kym Boycott has received research support from CIHR.
-
-
Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Böhringer Ingelheim. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROVI. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Böhringer Ingelheim. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacogeneitx. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GL Pharma. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Schwabe. Prof. Rujescu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ROVI. Prof. Rujescu has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Janssen.
-
Dr. Hartmann has nothing to disclose.
-
Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Brais has nothing to disclose.
-
Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
-
Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Matthis Synofzik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orphayzme Pharmaceuticals. The institution of Matthis Synofzik has received research support from EJPRD.